|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
ABSTRACT |
|---|
|
|
|---|
AM J RESPIR CRIT CARE MED 1999;160:S33
S37.COPD is a debilitating and progressive condition in which the airways become irreversibly obstructed
and the lungs progressively damaged. Unlike asthma, we know little about the cells that initiate and
drive this process. Research has shown that CD8+ T cells are overrepresented in the lungs of patients
with COPD and that they are inversely related to lung function. However, not all CD8+ T cells are alike
and subsets that make IFN-
but not IL-4 (Tc1), IL-4 but not IFN-
(Tc2) as well as those that make
both (Tc0) have been described. This article focuses on the characteristics of CD8+ T cell subsets and
considers their potential contribution to chronic obstructive pulmonary disease (COPD). Kemeny
DM, Vyas B, Vukmanovic-Stejic M, Thomas M, Noble A, Loh LC, O'Connor BJ. CD8+ T cell subsets and chronic obstructive pulmonary disease.
| |
INTRODUCTION |
|---|
|
|
|---|
To facilitate gas exchange the respiratory tract is in intimate contact with the outside world. For this reason, unlike the skin, it cannot be covered with a tough outer cuticle and is, therefore, highly susceptible to infection. The immune system plays a vital role in protecting the respiratory mucosa from infection. In addition to fighting infection, immune responses in this vulnerable tissue must be tightly regulated to prevent collateral damage. For example, a vigorous immune response is necessary to clear viral or bacterial infection but the same immune cells that do so are capable of causing extensive tissue damage if they continue to be active (1). The cells that orchestrate this response are immune T cells. The respiratory mucosa contains large numbers of T cells and a network of dendritic cells that present antigen to them.
| |
THE DIVISION OF LABOR BETWEEN CD4+ AND CD8+ T CELLS |
|---|
|
|
|---|
CD8+ T cells are MHC class I restricted while CD4+ T cells respond to antigenic peptides presented in the MHC class II cleft. The MHC I pathway collects antigen present in the cytosol of the cell such as viral or self-proteins that have been broken down into small peptides by the proteasome. Soluble protein antigens enter the MHC class II pathway (Figure 1). However, these two pathways are not completely exclusive and when antigen-presenting cells, such as macrophages, are activated by binding to plastic, their ability to process soluble antigen via the MHC I pathway is greatly enhanced (Figure 2). Apart from MHC restriction there are other differences between CD4+ and CD8+ T cells and these are summarized in Table 1. CD4+ T cells survive better than CD8+ T cells in culture. This may in part explain why much more is known about CD4+ T cell biology, as CD8+ T cells are difficult to propogate. CD8+ T cells more readily undergo apoptosis in culture unless rescued by specific cytokines or other stimuli. However, CD8+ T cells are remarkably resistant to Fas-induced apoptosis. This is not surprising as CD8+ T cells are capable of high levels of Fas ligand expression and use this to induce apoptosis in other cells (2). Finally, the generation of CD8+ T cells that make IL-2 and proliferate is inhibited by moderate (20 U/ ml) concentrations of interleukin 4 (IL-4) and IL-2 (3).
|
|
|
| |
CD4+ T CELL SUBSETS |
|---|
|
|
|---|
Until 1986 it was unclear how the different effector functions
of CD4+ T cells were organized. Different biological effects
were mediated by specific T cells but the molecular mechanisms were unclear. All this was changed by an article published by Mosmann and coworkers in 1986 (4), in which they
too classified a number of well-established mouse CD4+ T cell
clones according to the cytokines they produced. They observed that the clones could be polarized into those that secreted interferon
(IFN-
), IL-2, and tumor necrosis factor
(TNF-
) but not IL-4, IL-5, IL-6, and IL-10 or p600 (IL-13),
which they termed T helper 1 (Th1), and those that made IL-4,
IL-5, IL-6, and IL-10 or p600 (IL-13) but not IFN-
, IL-2, or
TNF-
, which they called T helper 2 (Th2). Some cytokines
such as TNF-
, IL-3, and granulocyte-macrophage colony-stimulating factor (GM-CSF) were produced in similar amounts
by both cell types. It soon became evident that Th1 cells were
associated with immunity to bacterial and viral pathogens
while Th2 responses were associated with nematode and other
parasitic infections and with IgE-mediated allergy and asthma.
A third category termed Th0, which made all cytokines, was
later described (5) and this has since been joined by Th3 cells
that make TGF-
(6) and Tr1 cells that mainly make IL-10 (7). These latter two types are believed to be involved in immune regulation.
Th2 cells can readily be found in the late-phase response
both in the lung (8) and after intradermal injection of antigen into the skin (11). Some of the cytokines secreted by these cells have direct proinflammatory effects. Both IL-4 and IL-5, for example, promote the recruitment and survival of eosinophils and mast cells (12), while IL-6 causes lung inflammation
IL-6-transgenic mice have a 20-fold increase in lung hyperresponsiveness (13, 14). Other cytokines made by both Th1 and
Th2 cells, such as GM-CSF, contribute to lung inflammation by
promoting monocyte activation and survival (15). Mice and
rats sensitized with ovalbumin have increased airway responses
to acetylcholine after ovalbumin aerosol challenge. T cells
alone duplicate this after passive transfer of antigen-primed
CD4+ T cells to naive animals (18, 19). The degree of hyperresponsiveness depends on the strength of the Th2 response and
the presence of CD8+ T cells (20). Thus T cells alone can cause
increased bronchial hyperresponsiveness in asthma.
In the lung Th1 responses are associated with infection with pathogenic organisms such as Mycobacterium tuberculosis (21, 22) and sarcoidosis (23). In addition to Th2 T cell- mediated pathology, Th1 cells, if unchecked, can cause inflammation and chronic tissue damage. Th1 cells induce neutrophil and macrophage infiltration and may promote granuloma formation.
CD8+ T cells are potentially damaging. This may explain
why they are more prone to activation-induced cell death, although not to Fas-mediated apoptosis. After activation in vivo
or in vitro with anti-CD3, CD8+ T cells are more likely to become apoptotic. Furthermore, when cultured with high concentrations of IL-4 or IL-2, CD8+ T cells become unresponsive and express lower levels of the IL-2R common
chain (3).
Thus these CD8+ T cell responses tend to be self-limiting under normal circumstances.
| |
CD8+ T CELL SUBSETS |
|---|
|
|
|---|
For a number of years it was believed that the Th1/Th2 paradigm did not apply to CD8+ T cells. Most CD8+ T cells had a Th1 cytokine profile and these cells rarely seemed to produce IL-4 (5). In the early 1990s this view began to be challenged: first by the observation, by Seder and colleagues (24), that mouse CD8+ T cells cultured with IL-2 and IL-4 made significant amounts of IL-4; then, in patients with leprosy, where Salgame and coworkers showed that CD8+ T cells that made IL-4 were associated with the more severe lepromatous form of the disease and could inhibit Mycobacterium leprae-specific cytotoxic CD4+ T cells (25, 26). Indeed, CD8+ T cells from naive rats made more IL-4 than did CD4+ T cells when stimulated with phorbol myristate acetate (PMA) and ionomycin (27).
CD8+ T cells can differentiate into cells that make IFN-
but no IL-4 (Tc1 cells) and cells that make IL-4 but not IFN-
(Tc2 cells) (28, 29). However, it is difficult to produce mouse or rat Tc2 cells (27) from wild-type (i.e., not transgenic) animals or human Tc2 CD8+ T cell clones (30), although there
are isolated reports of such cells obtained from the gingiva
(31) and peritoneum (32). By using appropriate stimuli we
have made mouse Tc1 and Tc2 cells (Figure 3) and human Tc1
and Tc2 cell clones. Unlike Th1 and Th2 CD4+ T cells, CD8+
T cell subsets appear to be equally cytolytic. However, the
level of toxicity appears to depend on the level of peptide-
MHC class I expression and possibly on the amount of costimulation. Furthermore, CD8+ T cell subsets respond differently
to cytokines. IL-12 enhances Tc1 but not Tc2 cell growth while
IL-4 inhibits Tc1 cell proliferation but has no effect on Tc2
cells. Finally, Tc1 and Tc2 cell clones differ in the level of cell
surface antigens they express, although it is not clear at what
stage of differentiation this takes place. In our hands, established human Tc1 CD8+ T cell clones express little CD30,
CD28, or CD40L while Tc2 cells express substantial amounts
of these ligands that may facilitate their interaction with other
immune cells.
|
| |
EFFECTOR FUNCTIONS OF CD8+ T CELL SUBSETS |
|---|
|
|
|---|
CD4+ and CD8+ T cells share common features but also exhibit marked differences summarized in Table 2. Tc1 and Tc2 CD8+ T cells injected into mice induce comparable inflammation (33). Unlike CD4+ Th1 and Th2 cells there is, however, no obvious difference in the resultant pathology. In the lung Th1 CD4+ T cells induce neutrophilia while Th2 cells induce eosinophilia. CD8+ Tc1 and Tc2 cells are equally cytotoxic (34) but only CD4 Th1 cells can induce killing of target cells.
|
| |
IMMUNE REGULATION BY CD8+ T CELL SUBSETS |
|---|
|
|
|---|
Shortly after IgE was discovered Tada and coworkers showed
that Ly2 (CD8
)-positive T cells inhibited IgE responses in
rats (35). Subsequently, Sedgwick and Holt showed that inhalation of ovalbumin (OVA) led to the activation of CD8+ T
cells that could inhibit IgE responses after adoptive transfer (38). The cells induced by this route of immunization expressed the 
form of the T cell receptor (TcR) (39). After exposure to castor bean dust we observed that normal as well as
atopic people became sensitized to castor bean proteins (40).
In a rat model we showed that the agent responsible was a
toxin, ricin, that selectively killed a population of CD8+ cells
(41, 42) and resulted in the enhancement of the IgE response
(43), reduced IFN-
production, and increased expression of
IL-4 (44), IL-5, and IL-10 (45). Depletion of CD8+ T cells 2 wk
after immunization enhanced the IgE response and also resulted in increased IL-4 and decreased IFN-
production by
CD4+ T cells (46). Cloned rat OVA-specific CD8+ T cells were
shown to be MHC class I restricted (47). Unlike the inhibitory
effects of virus-specific CD8+ T cells on lung eosinophilia described by Hussell and coworkers (48), which appear to be mediated by IFN-
, there was no difference in the amount of
IFN-
produced by cloned CD8+ T cells that differed 17-fold
in their ability to inhibit IgE (47). Furthermore, in more recent
experiments we have shown that both Tc1 and Tc2 OVA-specific CD8+ T cells and OVA-specific CD8+ T cells from IFN-
knockout mice are equally able to inhibit IgE. These cells do
not appear to suppress the production of IL-4-producing cells
but rather enhance the Th1 response. Thus any antigen getting into the MHC class I pathway at the beginning of an immune
response will tend to induce a response with a Th1 bias.
| |
CD8+ T CELLS IN ASTHMA |
|---|
|
|
|---|
CD8+ T cells appear to play different roles in asthma. As described by Hussell and colleagues for viruses (48), OVA-primed Tc1 CD8+ T cells inhibit Th2 CD4+ T cells and so prevent the development of bronchial hyperresponsiveness (BHR)
(20). Depletion of CD8+ T cells increases both the early-phase
(20) and the late-phase response (49) to OVA. This effect is
likely to be related to IFN-
. In patients, the presence of
CD8+ T cells in bronchoalveolar lavage (BAL) after experimental allergen challenge is negatively associated with a late-phase response (50). However, Tc2 CD8+ T cells may directly
contribute to airway inflammation in asthma. Coyle and colleagues (51) showed that in mice making a strong Th2 response, a concomitant CD8+ T cell response to viral infection
resulted in an increase in virus-specific CD8+ T cells that made
IL-5. Subsequent viral infection caused lung eosinophilia.
There is evidence for such a phenomenon in allergic patients,
where viral infections may contribute to asthma by increasing eosinophil infiltration (52).
| |
CD8+ T CELLS IN OTHER LUNG DISEASES |
|---|
|
|
|---|
CD8+ T Cells in Tuberculosis
CD8+ T cells are generally associated with Th1-type immune
responses. CD8+ T cells play an important role in the generation of protective immunity to Mycobacterium tuberculosis.
CD8+ T cells have been found in patients with chronic obstructive pulmonary disease (COPD) (53, 54). In mice Tough
and coworkers showed that tiny amounts of lipopolysaccharide
(LPS) from gram-negative bacteria caused selective activation
of CD8+ T cells (55). Previous studies in mice, including
2-microglobulin knockout mice, have suggested an important
role for CD8+ T cells in host defense to M. tuberculosis (56,
57). Immunization of mice with heat-killed Mycobacterium
vaccae induces CD8+ T cells specific for M. tuberculosis-infected macrophages (58). In humans CD8+ T cells specific for
M. tuberculosis have been described (59, 60).
CD8+ T Cells and COPD
Relatively little is known about T cells and COPD. O'Shaughnessy and colleagues (53) showed that increased numbers of CD8+ T cells were present in the lungs of patients with COPD. A similar finding was reported by Saetta and coworkers (61) and de Jong and colleagues showed that CD8+ T cell numbers in the peripheral blood were increased in patients with COPD relative to CD4+ T cells. The CD4+/CD8+ T cell ratio in these patients was negatively correlated with lung function and serum IgE levels (62). However, we still know little about the kinetics of CD8+ T cell recruitment, their interaction with CD4+ T cells, and their contribution to the pathology of COPD.
| |
FUTURE QUESTIONS |
|---|
|
|
|---|
Clearly we need to know more about the role of different immune cells, and CD8+ T cells in particular, in COPD. Some of these questions may be addressed by monitoring "at risk" patients, but this will be time consuming and expensive. Investigation of large cohorts of patients with COPD may make it possible to identify groups with common factors such as an absence of cigarette smoking. Cigarette smoking exerts different effects on the immune system at different doses, which further compounds the interpretation of results. Animal experiments will allow us to model mechanisms but these will always need to be verified against the human disease.
| |
Footnotes |
|---|
Correspondence and requests for reprints should be addressed to Professor David M. Kemeny, Department of Immunology, GKT, Rayne Institute, 123 Coldharbour Lane, London SE5 9NU, UK. E-mail: david.kemeny{at}kcl.ac.uk
Acknowledgments: Supported by research grants from the Wellcome Trust, the Medical Research Council, Bayer Yakuhin, and Glaxo Wellcome.
| |
References |
|---|
|
|
|---|
1.
Cannon, M. J.,
P. J. Openshaw, and
B. A. Askonas.
1988.
Cytotoxic T
cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus.
J. Exp. Med.
168:
1163-1168
2.
Noble, A.,
G. A. Pestano, and
H. Cantor.
1998.
Suppression of immune
responses by CD8 cells: I. Superantigen-activated CD8 cells induce
unidirectional Fas-mediated apoptosis of antigen-activated CD4 cells.
J. Immunol.
160:
559-565
3. Vyas, B., M. Vukmanovic-Stejic, A. Noble, and D. M. Kemeny. 1999. IL-4 inhibits human CD8 T cell expression of the common IL-2 receptor gamma chain (gc). Int. Arch. Allergy Appl. Immunol. 118: 433-436 .
4. Mosmann, T. R., H. Cherwinski, M. W. Bond, M. A. Giedlin, and R. L. Coffman. 1986. Two types of murine helper T cell clones: 1. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 135: 2348-2357 .
5. Paliard, X., R. de Waal, Malefijt, H. Yssel, D. Blanchard, I. Chretien, J. Abrams, J. de Vries, and H. Spits. 1988. A Simultaneous production of IL-2, IL-4, and IFN-gamma by activated human CD4 and CD8 T cell clones. J. Immunol. 141: 849-855 [Abstract].
6.
Miller, A.,
O. Lider,
A. B. Roberts,
M. B. Sporn, and
H. L. Weiner.
1992.
Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering.
Proc. Natl. Acad. Sci. U.S.A.
89:
421-425
7. Groux, H., A. O'Garra, M. Bigler, M. Rouleau, S. Antonenko, J. E. de Vries, and M. G. Roncarolo. 1997. CD4 T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature (London) 389: 737-742 [Medline].
8. Azzawi, M., B. Bradley, P. K. Jeffery, A. J. Frew, A. J. Wardlaw, G. Knowles, B. Assoufi, J. V. Collins, S. Durham, and A. B. Kay. 1990. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am. Rev. Respir. Dis. 142: 1407-1413 [Medline].
9. Corrigan, C. J., and A. B. Kay. 1990. CD4 T-lymphocyte activation in acute severe asthma: relationship to disease severity and atopic status. Am. Rev. Respir. Dis. 141: 970-977 [Medline].
10. Robinson, D. S., Q. Hamid, S. Ying, A. Tsicopoulos, J. Barkans, A. M. Bentley, C. Corrigan, S. R. Durham, and A. B. Kay. 1992. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326: 298-304 [Abstract].
11. Frew, A. J., and A. B. Kay. 1988. The relationship between infiltrating CD4 lymphocytes, activated eosinophils, and the magnitude of the allergen-induced late phase cutaneous reaction in man. J. Immunol. 141: 4158-4164 [Abstract].
12. Moser, R., J. Fehr, and P. L. Bruijnzeel. 1992. IL-4 controls the selective endothelium-driven transmigration of eosinophils from allergic individuals. J. Immunol. 149: 1432-1438 [Abstract].
13. Di Cosmo, B. F., G. P. Geba, D. Picarella, J. A. Elias, J. A. Rankin, B. R. Stripp, J. A. Whitsett, and R. A. Flavell. 1994. Airway epithelial cell expression of interleukin-6 in transgenic mice: uncoupling of airway inflammation and bronchial hyperreactivity. J. Clin. Invest. 94: 2028-2035 .
14. Di Cosmo, B., G. Geba, D. Picarella, J. A. Elias, J. A. Rankin, B. Stripp, J. A. Whitsett, and R. A. Flavell. 1995. Expression of interleukin-6 by airway epithelial cells: effects on airway inflammation and hyperreactivity in transgenic mice. Chest 107(Suppl. 3):131S.
15. Hallsworth, M. P., C. P. Soh, S. J. Lane, J. P. Arm, and T. H. Lee. 1994. Selective enhancement of GM-CSF, TNF-alpha, IL-1 beta and IL-8 production by monocytes and macrophages of asthmatic subjects. Eur. Respir. J. 7: 1096-1102 [Abstract].
16.
Sousa, A. R.,
B. E. Lams,
R. Pfister,
P. E. Christie,
M. Schmitz, and
T. H. Lee.
1997.
Expression of interleukin-5 and granulocyte-macrophage
colony-stimulating factor in aspirin-sensitive and non-aspirin-sensitive
asthmatic airways.
Am. J. Respir. Crit. Care Med.
156:
1384-1389
17. Caulfield, J. J., C. M. Hawrylowicz, D. M. Kemeny, and T. H. Lee. 1997. GM-CSF increases the ability of cultured macrophages to support autologous CD4 T-cell proliferation in response to Dermatophagoides pteronyssinus and PPD antigen. Immunology 92: 123-130 [Medline].
18. Haczku, A., P. Macary, E. B. Haddad, T. J. Huang, D. M. Kemeny, R. Moqbel, and K. F. Chung. 1996. Expression of Th-2 cytokines interleukin-4 and -5 and of Th-1 cytokine interferon-gamma in ovalbumin-exposed sensitized Brown-Norway rats. Immunology 88: 247-251 [Medline].
19. Haczku, A., P. Macary, T. J. Huang, H. Tsukagoshi, P. J. Barnes, A. B. Kay, D. M. Kemeny, K. F. Chung, and R. Moqbel. 1997. Adoptive transfer of allergen-specific CD4+ T cells induces airway inflammation and hyperresponsiveness in Brown-Norway rats. Immunology 91: 176-185 [Medline].
20. Huang, T.-J., P. A. MacAry, D. M. Kemeny, and K. F. Chung. 1999. Effect of CD8 T-cell depletion on bronchial hyperresponsiveness and inflammation in sensitised and allergen-exposed Brown-Norway rats. Immunology 96: 416-423 [Medline].
21.
Lai, C. K.,
S. Ho,
C. H. Chan,
J. Chan,
D. Choy,
R. Leung, and
K. N. Lai.
1997.
Cytokine gene expression profile of circulating CD4 T cells in
active pulmonary tuberculosis.
Chest
111:
606-611
22. Zhu, X., N. Venkataprasad, H. S. Thangaraj, M. Hill, M. Singh, J. Ivanyi, and H. M. Vordermeier. 1997. Functions and specificity of T cells following nucleic acid vaccination of mice against Mycobacterium tuberculosis infection. J. Immunol. 158: 5921-5926 [Abstract].
23. Milburn, H. J., L. W. Poulter, A. Dilmec, G. M. Cochrane, and D. M. Kemeny. 1997. Corticosteroids restore the balance between locally produced Th1 and Th2 cytokines and immunoglobulin isotypes to normal in sarcoid lung. Clin. Exp. Immunol. 108: 105-113 [Medline].
24.
Seder, R. A.,
W. E. Paul,
M. M. Davis, and
B. Fazekas de St. Groth.
1992.
The presence of interleukin 4 during in vitro priming determines
the lymphokine-producing potential of CD4 T cells from T cell receptor transgenic mice.
J. Exp. Med.
176:
1091-1098
25.
Salgame, P.,
J. Convit, and
B. R. Bloom.
1991.
Immunological suppression by human CD8 T cells is receptor dependent and HLA-DQ restricted.
Proc. Natl. Acad. Sci. U.S.A.
88:
2598-2602
26.
Salgame, P.,
J. S. Abrams,
C. Clayberger,
H. Goldstein,
J. Convit,
R. L. Modlin, and
B. R. Bloom.
1991.
Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones.
Science
254:
279-282
27. Noble, A., P. A. Macary, and D. M. Kemeny. 1995. IFN-gamma and IL-4 regulate the growth and differentiation of CD8 T cells into subpopulations with distinct cytokine profiles. J. Immunol. 155: 2928-2937 [Abstract].
28. Sad, S., R. Marcotte, and T. R. Mosmann. 1995. Cytokine-induced differentiation of precursor mouse CD8 T cells into cytotoxic CD8 T cells secreting Th1 or Th2 cytokines. Immunity 2: 271-279 [Medline].
29.
Croft, M.,
L. Carter,
S. L. Swain, and
R. W. Dutton.
1994.
Generation of
polarized antigen-specific CD8 effector populations: reciprocal action
of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles.
J. Exp. Med.
180:
1715-1728
30. Vukmanovic-Stejic, M., B. Vyas, P. Gorak-Stolinska, A. Noble, and D. M. Kemeny. 1999. Human Tc1 and Tc2/Tc0 CD8 T cell clones display distinct cell surface and functional phenotypes. Blood (In press)
31. Wassenaar, A., C. Reinhardus, L. Abraham-Inpijn, and F. Kievits. 1996. Type-1 and type-2 CD8 T-cell subsets isolated from chronic adult periodontitis tissue differ in surface phenotype and biological functions. Immunology 87: 113-118 [Medline].
32. Birkhofer, A., J. Rehbock, and H. Fricke. 1996. T lymphocytes from the normal human peritoneum contain high frequencies of Th2-type CD8 T cells. Eur. J. Immunol. 26: 957-960 [Medline].
33. Li, L., S. Sad, D. Kagi, and T. R. Mosmann. 1997. CD8 Tc1 and Tc2 cells secrete distinct cytokine patterns in vitro and in vivo but induce similar inflammatory reactions. J. Immunol. 158: 4152-4161 [Abstract].
34.
Sad, S., and
T. R. Mosmann.
1995.
Interleukin (IL) 4, in the absence of
antigen stimulation, induces an anergy-like state in differentiated
CD8 TC1 cells: loss of IL-2 synthesis and autonomous proliferation
but retention of cytotoxicity and synthesis of other cytokines.
J. Exp.
Med.
182:
1505-1515
35.
Okumura, K. O., and
T. Tada.
1971.
Regulation of homocytotrophic antibody formation in the rat: III. Effect of thymectomy and splenectomy.
J. Immunol.
106:
1019-1026
36.
Okumura, K. O., and
T. Tada.
1971.
Regulation of homocytotrophic antibody formation in the rat: IV. Inhibitory effect of thymocytes on the
homocytotrophic antibody response.
J. Immunol.
107:
1682-1689
37.
Okumura, K.,
T. Takemori,
T. Tokuhisa, and
T. Tada.
1977.
Specific enrichment of the suppressor T cell bearing I-J determinants: parallel functional and serological characterizations.
J. Exp. Med.
146:
1234-1245
38. Sedgwick, J. D., and P. G. Holt. 1984. Suppression of IgE responses in inbred rats by repeated respiratory tract exposure to antigen: responder phenotype influences isotype specificity of induced tolerance. Eur. J. Immunol. 14: 893-897 [Medline].
39.
McMenamin, C., and
P. G. Holt.
1993.
The natural immune response to
inhaled soluble protein antigens involves major histocompatability
complex (MHC) class-I-restricted CD8 T cell mediated, but MHC
class II-restricted CD4 T cell-dependent immune deviation resulting
in selective suppression of immunoglobulin E production.
J. Exp. Med.
178:
889-899
40. Thorpe, S. C., D. M. Kemeny, R. Panzani, and M. H. Lessof. 1988. Allergy to castor bean: I. Its relationship to sensitization to common inhalant allergens (atopy). J. Allergy Clin. Immunol. 82: 62-66 [Medline].
41. Diaz-Sanchez, D., and D. M. Kemeny. 1990. The sensitivity of rat CD8 and CD4 T cells to ricin in vivo and in vitro and their relationship to IgE regulation. Immunology 69: 71-77 [Medline].
42. Diaz-Sanchez, D., and D. M. Kemeny. 1991. Generation of a long-lived IgE response in high and low responder strains of rat by co-administration of ricin and antigen. Immunology 72: 297-303 [Medline].
43. Diaz-Sanchez, D., T. H. Lee, and D. M. Kemeny. 1993. Ricin enhances IgE responses by inhibiting a subpopulation of early-activated CD8 T cells. Immunology 78: 226-236 [Medline].
44.
Diaz-Sanchez, D.,
A. Noble,
D. Z. Staynov,
T. H. Lee, and
D. M. Kemeny.
1993.
Elimination of IgE regulatory CD8 T cells in vivo differentially modulates the ability of splenocytes to produce IL-4 and IFN-
but not IL-2.
Immunology
78:
513-519
[Medline].
45. Noble, A., D. Diaz-Sanchez, D. Staynov, T. Lee, and D. M. Kemeny. 1993. Elimination of IgE regulatory rat CD8 T cells in vivo increases the co-ordinate expression of the Th2 cytokines IL-4, IL-5 and IL-10. Immunology 80: 326-329 [Medline].
46. Holmes, B. J., P. A. MacAry, A. Noble, and D. M. Kemeny. 1997. Antigen-specific CD8 T cells inhibit IgE responses and IL-4 production by CD4 T cells. Eur. J. Immunol. 27: 2657-2665 [Medline].
47.
MacAry, P. A.,
B. J. Holmes, and
D. M. Kemeny.
1998.
Ovalbumin-specific, MHC class I-restricted, alpha beta-positive, Tc1 and Tc0 CD8 T
cell clones mediate the in vivo inhibition of rat IgE.
J. Immunol.
160:
580-587
48. Hussell, T., C. J. Baldwin, A. O'Garra, and P. J. Openshaw. 1997. CD8 T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection. Eur. J. Immunol. 27: 3341-3349 [Medline].
49. Olivenstein, R., P. M. Renzi, J. P. Yang, P. Rossi, S. Laberge, S. Waserman, and J. G. Martin. 1993. Depletion of OX-8 lymphocytes from the blood and airways using monoclonal antibodies enhances the late airway response in rats. J. Clin. Invest. 92: 1477-1482 .
50. Gonzalez, M. C., P. Diaz, F. R. Galleguillos, P. Ancic, O. Cromwell, and A. B. Kay. 1987. Allergen-induced recruitment of bronchoalveolar helper (OKT4) and suppressor (OKT8) T-cells in asthma: relative increases in OKT8 cells in single early responders compared with those in late-phase responders. Am. Rev. Respir. Dis. 136: 600-604 [Medline].
51.
Coyle, A. J.,
F. Erard,
C. Bertrand,
S. Walti,
H. Pircher, and
G. Le Gros.
1995.
Virus-specific CD8 cells can switch to interleukin 5 production
and induce airway eosinophilia.
J. Exp. Med.
181:
1229-1233
52. Bardin, P. G., D. J. Fraenkel, G. Sanderson, F. Lampe, and S. T. Holgate. 1995. Lower airways inflammatory response during rhinovirus colds. Int. Arch. Allergy Immunol. 107: 127-129 [Medline].
53. O'Shaughnessy, T. C., T. W. Ansari, N. C. Barnes, and P. K. Jeffery. 1997. Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8 T lymphocytes with FEV1. Am. J. Respir. Crit. Care Med. 155: 852-857 [Abstract].
54. Jeffery, P. K.. 1998. Structural and inflammatory changes in COPD: a comparison with asthma. Thorax 53: 129-136 [Medline].
55.
Tough, D. F.,
S. Sun, and
J. Sprent.
1997.
T cell stimulation in vivo by lipopolysaccharide (LPS).
J. Exp. Med.
185:
2089-2094
56. Zugel, U., B. Schoel, and S. H. Kaufmann. 1994. Beta 2-microglobulin independent presentation of exogenously added foreign peptide and endogenous self-epitope by MHC class I alpha-chain to a cross-reactive CD8 CTL clone. J. Immunol. 153: 4070-4080 [Abstract].
57. Flynn, J. L., M. M. Goldstein, K. J. Triebold, and B. R. Bloom. 1993. Major histocompatibility complex class I-restricted T cells are necessary for protection against M. tuberculosis in mice. Infect. Agents Dis. 2: 259-262 [Medline].
58. Skinner, M. A., S. Yuan, R. Prestidge, D. Chuk, J. D. Watson, and P. L. Tan. 1997. Immunization with heat-killed Mycobacterium vaccae stimulates CD8 cytotoxic T cells specific for macrophages infected with Mycobacterium tuberculosis. Infect. Immun. 65: 4525-4530 [Abstract].
59.
Lewinsohn, D. M.,
M. R. Alderson,
A. L. Briden,
S. R. Riddell,
S. G. Reed, and
K. H. Grabstein.
1998.
Characterization of human CD8 T
cells reactive with Mycobacterium tuberculosis-infected antigen-presenting cells.
J. Exp. Med.
187:
1633-1640
60.
Lalvani, A.,
R. Brookes,
R. J. Wilkinson,
A. S. Malin,
A. A. Pathan,
P. Andersen,
H. Dockrell,
G. Pasvol, and
A. V. Hill.
1998.
Human cytolytic and interferon gamma-secreting CD8 T lymphocytes specific for
Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U.S.A.
95:
270-275
.
61.
Saetta, M.,
A. Di Stefano,
G. Turato,
F. M. Facchini,
L. Corbino,
C. E. Mapp,
P. Maestrelli,
A. Ciaccia, and
L. M. Fabbri.
1998.
CD8 T-lymphocytes in peripheral airways of smokers with chronic obstructive
pulmonary disease.
Am. J. Respir. Crit. Care Med.
157:
822-826
62. de Jong, J. W., B. van der Belt-Gritter, G. H. Koeter, and D. S. Postma. 1997. Peripheral blood lymphocyte cell subsets in subjects with chronic obstructive pulmonary disease: association with smoking, IgE and lung function. Respir. Med. 91: 67-76 [Medline].
This article has been cited by other articles:
![]() |
K. Zhang, L. Shan, M. S. Rahman, H. Unruh, A. J. Halayko, and A. S. Gounni Constitutive and inducible thymic stromal lymphopoietin expression in human airway smooth muscle cells: role in chronic obstructive pulmonary disease Am J Physiol Lung Cell Mol Physiol, August 1, 2007; 293(2): L375 - L382. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Xystrakis, P. Cavailles, A. S. Dejean, B. Cautain, C. Colacios, D. Lagrange, M.-J. van de Gaar, I. Bernard, D. Gonzalez-Dunia, J. Damoiseaux, et al. Functional and Genetic Analysis of Two CD8 T Cell Subsets Defined by the Level of CD45RC Expression in the Rat J. Immunol., September 1, 2004; 173(5): 3140 - 3147. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Panzner, J.-J. Lafitte, A. Tsicopoulos, Q. Hamid, and M. K. Tulic Marked Up-regulation of T Lymphocytes and Expression of Interleukin-9 in Bronchial Biopsies From Patients With Chronic Bronchitis With Obstruction Chest, November 1, 2003; 124(5): 1909 - 1915. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Irifune, A. Yokoyama, N. Kohno, K. Sakai, and K. Hiwada T-helper 1 cells induce alveolitis but do not lead to pulmonary fibrosis in mice Eur. Respir. J., January 1, 2003; 21(1): 11 - 18. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ichiyama, M. Nishikawa, T. Yoshitomi, S. Hasegawa, T. Matsubara, T. Hayashi, and S. Furukawa Clarithromycin Inhibits NF-{kappa}B Activation in Human Peripheral Blood Mononuclear Cells and Pulmonary Epithelial Cells Antimicrob. Agents Chemother., January 1, 2001; 45(1): 44 - 47. [Abstract] [Full Text] |
||||
![]() |
Z. Wang, T. Zheng, Z. Zhu, R. J. Homer, R. J. Riese, H. A. Chapman , Jr., S. D. Shapiro, and J. A. Elias Interferon {{gamma}} Induction of Pulmonary Emphysema in the Adult Murine Lung J. Exp. Med., December 4, 2000; 192(11): 1587 - 1600. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Cell Mol. Biol. |